Large animal models of atherosclerosis - New tools for persistent problems in cardiovascular medicine

Journal of Pathology

Volumn 238, Issue 2, 2016, Pages 257-266

  Shim, J ^a   Al Mashhadi, R H ^a   Sorensen C B ^a   Bentzon, J F ^a,b  

^a AARHUS UNIVERSITY   (Denmark)

^b CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

animal models; atherosclerosis; genetically modified animals; pathology

Indexed keywords

ANIMAL MODEL; ATHEROSCLEROSIS; DIABETES MELLITUS; DIAGNOSTIC IMAGING; DISEASE COURSE; DRUG DEVELOPMENT; HUMAN; HYPERTENSION; LIPOPROTEIN METABOLISM; MINIPIG; MOUSE MODEL; NONHUMAN; PATHOGENESIS; PORCINE MODEL; PRIMATE MODEL; PRIORITY JOURNAL; RABBIT MODEL; REVIEW; SPONTANEOUS MUTATION; TRANSLATIONAL RESEARCH; ANIMAL; DISEASE MODEL; FORECASTING; GENETIC ENGINEERING; MOUSE; PIG; PRECLINICAL STUDY; PROCEDURES; RABBIT; TRANSGENIC ANIMAL;

CARDIOVASCULAR AGENT;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ATHEROSCLEROSIS; CARDIOVASCULAR AGENTS; DIAGNOSTIC IMAGING; DISEASE MODELS, ANIMAL; DRUG DISCOVERY; DRUG EVALUATION, PRECLINICAL; FORECASTING; GENETIC ENGINEERING; HUMANS; MICE; RABBITS; SWINE; SWINE, MINIATURE;

EID: 84951270901     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4646     Document Type: Review

References (66)

1. Getz GS, Reardon CA,. Animal models of atherosclerosis. Arterioscler Thromb Vasc Biol 2012; 32: 1104-1115.
2. Hopkins PN,. Molecular biology of atherosclerosis. Physiol Rev 2013; 93: 1317-1542.
3. Stein EA, Raal F,. Reduction of low-density lipoprotein cholesterol by monoclonal antibody inhibition of PCSK9. Annu Rev Med 2014; 65: 417-431.
4. Libby P, Ridker PM, Hansson GK,. Progress and challenges in translating the biology of atherosclerosis. Nature 2011; 473: 317-325.
5. Plump AS, Lum PY,. Genomics and cardiovascular drug development. J Am Coll Cardiol 2009; 53: 1089-1100.
6. Schlendorf KH, Nasir K, Blumenthal RS,. Limitations of the Framingham risk score are now much clearer. Prev Med 2009; 48: 115-116.
7. Martin SS, Blumenthal RS, Miller M,. LDL cholesterol: the lower the better. Med Clin North Am 2012; 96: 13-26.
8. Nordestgaard BG, Chapman MJ, Humphries SE, et al., Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society. Eur Heart J 2013; 34: 3478-3490.
9. Lim SS, Vos T, Flaxman AD, et al., A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2224-2260.
10. Yusuf S, Hawken S, Ounpuu S, et al., Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937-952.
11. Steinberg D, Glass CK, Witztum JL,. Evidence mandating earlier and more aggressive treatment of hypercholesterolemia. Circulation 2008; 118: 672-677.
12. Tabas I, Williams KJ, Borén J,. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 2007; 116: 1832-1844.
13. Miller YI, Choi SH, Wiesner P, et al., Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity. Circ Res 2011; 108: 235-248.
14. Libby P, Tabas I, Fredman G, et al., Inflammation and its resolution as determinants of acute coronary syndromes. Circ Res 2014; 114: 1867-1879.
15. Steinberg D,. The LDL modification hypothesis of atherogenesis: an update. J Lipid Res 2009; 50 (suppl): S376-381.
16. Bentzon JF, Otsuka F, Virmani R, et al., Mechanisms of plaque formation and rupture. Circ Res 2014; 114: 1852-1866.
17. Falk E, Nakano M, Bentzon JF, et al., Update on acute coronary syndromes: the pathologists' view. Eur Heart J 2013; 34: 719-728.
18. Getz GS,. Diet and murine atherosclerosis. Arterioscler Thromb Vasc Biol 2005; 26: 242-249.
19. Gerrity RG, Natarajan R, Nadler JL, et al., Diabetes-induced accelerated atherosclerosis in swine. Diabetes 2001; 50: 1654-1665.
20. Bentzon JF, Falk E,. Atherosclerotic lesions in mouse and man: is it the same disease? Curr Opin Lipidol 2010; 21: 434-440.
21. Schwartz SM, Galis ZS, Rosenfeld ME, et al., Plaque rupture in humans and mice. Arterioscler Thromb Vasc Biol 2007; 27: 705-713.
22. Armstrong ML, Heistad DD,. Animal models of atherosclerosis. Atherosclerosis 1990; 85: 15-23.
23. Plump AS, Smith JD, Hayek T, et al., Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992; 71: 343-353.
24. Zhang SH, Reddick RL, Piedrahita JA, et al., Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992; 258: 468-471.
25. Ishibashi S, Goldstein JL, Brown MS, et al., Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J Clin Invest 1994; 93: 1885-1893.
26. Tadin-Strapps M, Peterson LB, Cumiskey A-M, et al., siRNA-induced liver ApoB knockdown lowers serum LDL-cholesterol in a mouse model with human-like serum lipids. J Lipid Res 2011; 52: 1084-1097.
27. Herbert B, Patel D, Waddington SN, et al., Increased secretion of lipoproteins in transgenic mice expressing human D374Y PCSK9 under physiological genetic control. Arterioscler Thromb Vasc Biol 2010; 30: 1333-1339.
28. Bjørklund MM, Hollensen AK, Hagensen MK, et al., Induction of atherosclerosis in mice and hamsters without germline genetic engineering. Circ Res 2014; 114: 1684-1689.
29. Daugherty A, Tabas I, Rader DJ,. Accelerating the pace of atherosclerosis research. 2015; 35: 11-12.
30. Virmani R, Kolodgie FD, Burke AP, et al., Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 2005; 25: 2054-2061.
31. Zhou J, Møller J, Danielsen CC, et al., Dietary supplementation with methionine and homocysteine promotes early atherosclerosis but not plaque rupture in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 2001; 21: 1470-1476.
32. Watanabe Y., Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbit). Atherosclerosis 1980; 36: 261-268.
33. Ardern HA, Benson GM, Suckling KE, et al., Apolipoprotein B overproduction by the perfused liver of the St. Thomas' mixed hyperlipidemic (SMHL) rabbit. J Lipid Res 1999; 40: 2234-2243.
34. Ji D, Zhao G, Songstad A, et al., Efficient creation of an APOE knockout rabbit. Transgen Res 2014; 24: 227-235.
35. Bocan TM, Mueller SB, Mazur MJ, et al., The relationship between the degree of dietary-induced hypercholesterolemia in the rabbit and atherosclerotic lesion formation. Atherosclerosis 1993; 102: 9-22.
36. Shiomi M., Development of an animal model for spontaneous myocardial infarction (WHHLMI rabbit). Arterioscler Thromb Vasc Biol 2003; 23: 1239-1244.
37. Kaplan JR, Manuck SB,. Status, stress, and atherosclerosis: the role of environment and individual behavior. Ann N Y Acad Sci 1999; 896: 145-161.
38. Niu Y, Bin Shen, Cui Y, et al., Generation of gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in one-cell embryos. Cell 2014; 156: 836-843.
39. Al-Mashhadi RH, Sorensen CB, Kragh PM, et al., Familial hypercholesterolemia and atherosclerosis in cloned minipigs created by DNA transposition of a human PCSK9 gain-of-function mutant. Sci Transl Med 2013; 5: 166ra1.
40. Thim T, Hagensen MK, Drouet L, et al., Familial hypercholesterolaemic downsized pig with human-like coronary atherosclerosis: a model for preclinical studies. EuroIntervention 2010; 6: 261-268.
41. Davis BT, Wang X-J, Rohret JA, et al., Targeted disruption of LDLR causes hypercholesterolemia and atherosclerosis in Yucatan miniature pigs. PLoS One 2014; 9: e93457.
42. Agarwala A, Billheimer J, Rader DJ,. Mighty minipig in fight against cardiovascular disease. Sci Transl Med 2013; 5: 166fs1.
43. Hamamdzic D, Wilensky RL,. Porcine models of accelerated coronary atherosclerosis: role of diabetes mellitus and hypercholesterolemia. J Diabetes Res 2013; 2013: 761415.
44. Prescott MF, McBride CH, Hasler-Rapacz J, et al., Development of complex atherosclerotic lesions in pigs with inherited hyper-LDL cholesterolemia bearing mutant alleles for apolipoprotein B. Am J Pathol 1991; 139: 139-147.
45. Hasler-Rapacz J, Ellegren H, Fridolfsson AK, et al., Identification of a mutation in the low density lipoprotein receptor gene associated with recessive familial hypercholesterolemia in swine. Am J Med Genet 1998; 76: 379-386.
46. Wilensky RL, Shi Y, Mohler ER, et al., Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development. Nat Med 2008; 14: 1059-1066.
47. Koskinas KC, Feldman CL, Chatzizisis YS, et al., Natural history of experimental coronary atherosclerosis and vascular remodeling in relation to endothelial shear stress: a serial, in vivo intravascular ultrasound study. Circulation 2010; 121: 2092-2101.
48. Koskinas KC, Sukhova GK, Baker AB, et al., Thin-capped atheromata with reduced collagen content in pigs develop in coronary arterial regions exposed to persistently low endothelial shear stress. Arterioscler Thromb Vasc Biol 2013; 33: 1494-1504.
49. Patel D, Hamamdzic D, Llano R, et al., Subsequent development of fibroatheromas with inflamed fibrous caps can be predicted by intracoronary near infrared spectroscopy. Arterioscler Thromb Vasc Biol 2013; 33: 347-353.
50. Al-Mashhadi RH, Bjørklund MM, Mortensen MB, et al., Diabetes with poor glycaemic control does not promote atherosclerosis in genetically modified hypercholesterolaemic minipigs. Diabetologia 2015; 58: 1926-1936.
51. Hammer RE, Pursel VG, Rexroad CE, et al., Production of transgenic rabbits, sheep and pigs by microinjection. Nature 1985; 315: 680-683.
52. Lai L, Kolber-Simonds D, Park K-W, et al., Production of α-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 2002; 295: 1089-1092.
53. Dai Y, Vaught TD, Boone J, et al., Targeted disruption of the α1,3-galactosyltransferase gene in cloned pigs. Nat Biotechnol 2002; 20: 251-255.
54. Soutar AK,. Unexpected roles for PCSK9 in lipid metabolism. Curr Opin Lipidol 2011; 22: 192-196.
55. Ekeløf S, Rosenberg J, Jensen JS, et al., Pharmacological attenuation of myocardial reperfusion injury in a closed-chest porcine model: a systematic review. J Cardiovasc Transl Res 2014; 7: 570-580.
56. Vilahur G, Padro T, Badimon L,. Atherosclerosis and thrombosis: insights from large animal models. J Biomed Biotechnol 2011; 2011: 907575.
57. Iqbal J, Chamberlain J, Francis SE, et al., Role of animal models in coronary stenting. Ann Biomed Eng 2015; DOI: 10.1007/s10439-015-1414-4.
58. Pedigri RM, Poulsen CB, Mehta VV, et al., Inducing persistent flow disturbances accelerates atherogenesis and promotes thin cap fibroatheroma development in D374Y-PCSK9 hypercholesterolemic minipigs. Circulation 2015; 132: 1003-1012.
59. Stone PH, Saito S, Takahashi S, et al., Prediction of progression of coronary artery disease and clinical outcomes using vascular profiling of endothelial shear stress and arterial plaque characteristics: the PREDICTION study. Circulation 2012; 126: 172-181.
60. Nair A., Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation 2002; 106: 2200-2206.
61. Gardner CM, Tan H, Hull EL, et al., Detection of lipid core coronary plaques in autopsy specimens with a novel catheter-based near-infrared spectroscopy system. JACC Cardiovasc Imaging 2008; 1: 638-648.
62. Thim T, Hagensen MK, Wallace-Bradley D, et al., Unreliable assessment of necrotic core by virtual histology intravascular ultrasound in porcine coronary artery disease. Circ Cardiovasc Imaging 2010; 3: 384-391.
63. The STABILITY, Investigators. Darapladib for preventing ischemic events in stable coronary heart disease. N Engl J Med 2014; 370: 1702-1711.
64. Fryburg DA, Vassileva MT,. Atherosclerosis drug development in jeopardy: the need for predictive biomarkers of treatment response. Sci Transl Med 2011; 3: 72cm6.
65. Rudd JHF, Narula J, Strauss HW, et al., Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time? J Am Coll Cardiol 2010; 55: 2527-2535.
66. Hai T, Teng F, Guo R, et al., One-step generation of knockout pigs by zygote injection of CRISPR/Cas system. Nature 2014; 24: 372-375.